Pay Attention to this Trade Activity as Tango Therapeutics Inc (TNGX) last week performance was 2.26%

As on Wednesday, Tango Therapeutics Inc (NASDAQ: TNGX) got off with the flyer as it spiked 1.59% to $7.68, before settling in for the price of $7.56 at the close. Taking a more long-term approach, TNGX posted a 52-week range of $2.47-$13.03.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 132.62%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -19.44%. This publicly-traded company’s shares outstanding now amounts to $102.20 million, simultaneously with a float of $52.47 million. The organization now has a market capitalization sitting at $819.61 million. At the time of writing, stock’s 50-day Moving Average stood at $10.67, while the 200-day Moving Average is $8.21.

Tango Therapeutics Inc (TNGX) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Tango Therapeutics Inc’s current insider ownership accounts for 50.83%, in contrast to 52.09% institutional ownership. According to the most recent insider trade that took place on Feb 20 ’24, this organization’s 10% Owner sold 162,500 shares at the rate of 12.00, making the entire transaction reach 1,950,000 in total value, affecting insider ownership by 19,201,475. Preceding that transaction, on Feb 07 ’24, Company’s Chief Executive Officer sold 4,457 for 12.62, making the whole transaction’s value amount to 56,246. This particular insider is now the holder of 1,535,167 in total.

Tango Therapeutics Inc (TNGX) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 12/30/2023, the company posted -$0.32 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.28) by -$0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.

Tango Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -19.44% and is forecasted to reach -1.39 in the upcoming year.

Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators

Let’s observe the current performance indicators for Tango Therapeutics Inc (TNGX). It’s Quick Ratio in the last reported quarter now stands at 7.54. The Stock has managed to achieve an average true range (ATR) of 0.55. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 22.44.

In the same vein, TNGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.10, a figure that is expected to reach -0.31 in the next quarter, and analysts are predicting that it will be -1.39 at the market close of one year from today.

Technical Analysis of Tango Therapeutics Inc (TNGX)

Through scrutinizing the latest numbers posted by the [Tango Therapeutics Inc, TNGX], it can be observed that its last 5-days Average volume of 0.87 million was better the volume of 0.69 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 32.30% While, its Average True Range was 0.51.

Raw Stochastic average of Tango Therapeutics Inc (TNGX) in the period of the previous 100 days is set at 13.06%, which indicates a major fall in contrast to 26.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 50.60% that was lower than 61.11% volatility it exhibited in the past 100-days period.